Cure8

Why This Matters

This mouse study suggests that acute colitis can alter liver immune responses—reducing CD8 T cells and shifting macrophages toward an anti-inflammatory M2 state—which may affect autoimmune cholangitis. That connection could matter for research into patients who have both IBD and autoimmune liver disease.

Who Should Pay Attention

Researchers (IBD–liver interaction, immunology), clinicians caring for patients with coexisting IBD and autoimmune cholestatic liver disease.

Study Snapshot

Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract

What To Know

This mouse study tested how experimentally induced acute colitis affects autoimmune cholangitis (a model of primary biliary cholangitis) when both gut and liver disease are present.

The researchers report that colitis worsened colon injury but reduced liver inflammation; in the liver, there were fewer CD8 T cells and a shift in macrophage polarization from M1 toward M2. The authors also measured changes in small-molecule metabolites that they propose could be linked to immune effects.

Keep In Mind

Preclinical mouse model; results may not generalize to humans. The paper reports mechanistic findings (immune cell changes, metabolite shifts) rather than clinical outcomes.

Source Details

Review the original publication for the complete reporting, methods, and context.

Read Original Source
Research paper Evidence type derived from source or registry metadata.
PublicationIn vivo (Athens, Greece)
AuthorsMiao He, Haoqing Liu, Miaomiao Zhang +4 more
InstitutionDepartment of Laboratory Medicine, Huangyan Hospital of Wenzhou Medical University, Taizhou First People's Hospital, Taizhou, P.R. China.
Study typeJournal article
Indexed viaPubMed
Source typeResearch paper
PublishedJan 1, 2026, 12:00 AM
Content availableJournal abstract

This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.

Related Reading

Browse latest news →